Quantcast

Latest Biocon Stories

2014-05-19 16:21:44

PHILADELPHIA, May 19, 2014 /PRNewswire-USNewswire/ -- Each year the Chemical Heritage Foundation (CHF) presents awards to innovators and leaders in the molecular sciences on Heritage Day. This year's awardees, who were honored on May 15, represent the highest achievement in very different fields. http://photos.prnewswire.com/prnvar/20140519/88877 Ronald Breslow, University Professor at Columbia University, was this year's recipient of the American Institute of Chemists (AIC)...

2014-05-16 23:03:55

The U.S. Pharmacopeial Convention (USP) congratulates Kiran Mazumdar-Shaw on receipt of the 2014 Othmer Gold Medal. Rockville, Md. (PRWEB) May 16, 2014 The U.S. Pharmacopeial Convention (USP) congratulates Kiran Mazumdar-Shaw on receipt of the 2014 Othmer Gold Medal. Established by the Chemical Heritage Foundation (CHF) in 1997, the award honors outstanding individuals who have made multifaceted contributions to chemical and scientific heritage through outstanding activity in such areas...

2014-01-21 16:21:23

She will accept CHF's top award at a dinner ceremony, the premier event of Heritage Day 2014 in Philadelphia. PHILADELPHIA, Jan. 21, 2014 /PRNewswire-USNewswire/ -- Kiran Mazumdar-Shaw, chairman and managing director, Biocon Limited, will receive the 2014 Othmer Gold Medal at the Chemical Heritage Foundation on Thursday, May 15. The Othmer Gold Medal presentation will be the premier event of CHF's 13th annual Heritage Day. (Photo:...

2014-01-02 12:22:28

PITTSBURGH, Jan. 2, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that Rakesh Bamzai has joined the company and has been appointed president, India Commercial and Emerging Markets. Bamzai has more than 20 years of experience in the Indian and global biopharmaceutical industry. Prior to joining Mylan, he was president of Marketing at Biocon, where he played a key role in building the company's global biopharmaceutical business. He had overall responsibility for active...

2013-12-10 23:20:12

Reportbuyer.com just published a new market research report: Biosimilar Opportunities in an Evolving Market. London (PRWEB) December 10, 2013 Biosimilars: another milestone passed At the end of June 2013, the European Medicines Agency’s Committee for Medical Products for Human Use issued a positive opinion for the first biosimilar version of Johnson & Johnson’s infliximab for the treatment of rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis. For the two...

2010-11-02 06:00:00

NEW YORK, Nov. 2, 2010 /PRNewswire-FirstCall/ -- Third-Quarter 2010 Revenues of $16.2 Billion Third-Quarter 2010 Adjusted Diluted EPS((1)) of $0.54; Reported Diluted EPS((2)) of $0.11 Tightens Ranges for 2010 Financial Guidance Components, Increases Range for Adjusted Diluted EPS((1)) and Reduces Range for Reported Diluted EPS((2)); Reaffirms 2012 Financial Targets Advances Strategic Priorities with Agreement to Acquire King Pharmaceuticals, Inc., Acquisition of FoldRx, Alliance with...

2010-10-18 06:00:00

BANGALORE, India and NEW YORK, Oct. 18 /PRNewswire/ -- Biocon, Asia's premier biotechnology company, and Pfizer Inc. (NYSE: PFE), the world's leading biopharmaceutical company, today announced that they have entered into a strategic global agreement for the worldwide commercialization of Biocon's biosimilar versions of Insulin and Insulin analog products: Recombinant Human Insulin, Glargine, Aspart and Lispro. Pfizer will have exclusive rights to commercialize these products globally,...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related